How much cash does Nuvectis Pharma have?

According to Nuvectis Pharma's latest annual financial reports, the company has a total of $18.53M in cash and cash equivalents. This amount includes all liquid assets that can be readily converted into cash.

Additionally, Nuvectis Pharma holds $- in short-term investments, which are highly liquid assets that can be easily converted into cash within a short period.

In total, the company has $18.53M when combining cash and cash equivalents with short-term investments.

On a per-share basis, Nuvectis Pharma has $1.08 in cash. This metric helps investors understand how much cash the company holds per outstanding share.

The company's free cash flow, which is the cash generated from operations after deducting capital expenditures, stands at $-12.25M. This is an important indicator of financial health, showing the cash available for distribution to shareholders or reinvestment into the company.

Lastly, the company's cash position has experienced a growth rate of -3.10%, reflecting the increase in cash and cash equivalents over the specified period.

Nuvectis Pharma Historical Cash on Hand

Cash on Hand History

The table below shows the amount of cash on hand for each year, with the latest data available for the last fiscal year 2024.

Year	Cash on Hand	Change
2024	$18.53M	-3.10%
2023	$19.13M	-4.34%
2022	$19.99M	248.19%
2021	$5.74M	N/A
2020	$-	N/A